Published: May 21, 2021 By Alex Keown
Biopharma and life sciences companies strengthen their leadership teams and board with these Movers & Shakers.
AavantiBio – Jessie Hanrahan was named chief regulatory officer of AavantiBio. Hanrahan will oversee global regulatory affairs for AavantiBio’s diversified pipeline of gene therapy programs targeting rare diseases with significant unmet medical needs. Most recently, she was Vice President of Regulatory Science at bluebird bio, Inc. Prior to bluebird bio, Hanrahan held positions of increasing responsibility at Genzyme Corp. where she worked across the oncology, multiple sclerosis and rare disease therapeutic areas. Earlier in her career, Hanrahan worked at Boston Scientific Corporation.
Eastern Shore Post
2
With a heavy heart I say goodbye to my dear Arthur, who passed away unexpectedly Monday, May 17, 2021. Born in Poughkeepsie, N.Y., Dec. 7, 1950. He attended medical school UNC Chapel Hill, did his residency at Duke University Medical Center, four years at Brook Army Medical Center in San Antonio, came to the Shore and became one of the radiologists of NAMH and worked there for over 20 years.
He leaves behind his wife, Jeanette; son, Robert; daughter, Rachael, and her sons, Riley, James, and Franklin; his mother, Daphne Fritz, of Burlington, Vt.; his brother, David, in Chicago; his sister, Marian, in Vermont; his brother, Tom, in Vermont; his niece, Kristina; and nephew, Elliot.
How to fix bad sleep habits caused by the pandemic
By: Erica Greenway
and last updated 2021-05-19 22:06:18-04
NORFOLK, Va. - More stress, changes to our schedules and more screen time over the past year have led to less of something we all need - sleep.
A recent survey from Mattress Firm found a lot of people aren t getting the recommended 7-9 hours of sleep a night. As a country, we really need to do better, said Dr. W. Chris Winter, a neurologist and sleep specialist.
While there are a lot of factors, one affecting many of us is electronics.
Therapeutic Rivaroxaban: Risk Outweighs Benefit in Stable COVID medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
A program designed to improve hospital care for patients with heart failure, the leading cause of hospitalization among adults over age 65, did not bring additional benefits beyond existing hospital quality improvement programs in a randomized controlled trial presented at the American College of Cardiology s 70th Annual Scientific Session.